SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-006929
Filing Date
2018-05-15
Accepted
2018-05-15 11:55:51
Documents
66
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 862176
2 ex10-23.htm EX-10.23 74423
3 ex10-24.htm EX-10.24 77847
4 ex31-1.htm EX-31.1 37350
5 ex32-1.htm EX-32.1 10678
  Complete submission text file 0001493152-18-006929.txt   4021353

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE imun-20180331.xml EX-101.INS 587326
7 XBRL SCHEMA FILE imun-20180331.xsd EX-101.SCH 52905
8 XBRL CALCULATION FILE imun-20180331_cal.xml EX-101.CAL 56067
9 XBRL DEFINITION FILE imun-20180331_def.xml EX-101.DEF 157703
10 XBRL LABEL FILE imun-20180331_lab.xml EX-101.LAB 312665
11 XBRL PRESENTATION FILE imun-20180331_pre.xml EX-101.PRE 248697
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 18834467
SIC: 2834 Pharmaceutical Preparations